Abstract Dinoflagellate genomes are large (up to 200 pg) and are encoded in histoneless chromosomes that are quasipermanently condensed. This unique combination of chromosomal characteristics presents additional topological and cell cycle control problems for a eukaryotic cell, potentially exhibiting novel regulatory requirements of topoisomerase II. The heterotrophic dinoflagellate Crypthecodinium cohnii was used in this study. The topoisomerase II activities throughout its cell cycle were investigated by DNA flow cytometry following enzyme deactivation. Fluorescence microscopy was also used for studying the chromosome morphology of the treated cells. Two classes of topoisomerase II inhibitors were applied in our study, both of which caused G 1 delay as well as G 2 /M arrest in the C. cohnii cell cycle. At high doses, the topoisomerase poisons amsacrine and ellipticine induced DNA fragmentation in C. cohnii cells. Topoisomerase II activities, as measured by the ability to decatenate kinetoplastid DNA (kDNA), are normally detected throughout the cell cycle in C. cohnii. Our results suggest that the requirement of type II topoisomerase activities during the G 1 phase of the cell cycle may relate to the unwinding of quasi-permanently condensed chromosomes for the purpose of transcription. This was also the first time that topoisomerase II activity in dinoflagellate cells was detected.
Introduction
The genomes of dinoflagellates are large and circular, as well as quasi-permanently condensed , presenting very unusual chromosome topology that probably exhibits novel regulatory requirements of topoisomerase. Dinoflagellate chromosomes are also devoid of nucleosome structures (Bodansky et al. 1979) and histone proteins (Rizzo 1981; Rizzo et al. 1984) . Chromosomal proteins rich in basic amino acids have been isolated (Rizzo 1981 (Rizzo , 1984 , but the protein-to-DNA ratio in dinoflagellate chromosomes is lower than that in bacteria. At high concentrations (over 200 mg/ml), DNA exists in liquid crystal states in vitro (Leforestier and Livolant 1992) . Dinoflagellate genome sizes range from 3.2 to more than 200 pg per cell. For Amphidinium carterae, a dinoflagellate with one of the smallest known genome, the concentration of DNA was estimated to be 200 mg/ml (Bohrmann et al. 1993) . From a physiochemical standpoint, these properties make it likely that dinoflagellate DNA/ chromosomes occur in liquid crystal states.
Under conventional transmission electron microscopy (TEM), dinoflagellate chromosomes show characteristic periodic structures, including bands, arches, and crenelations. Several models have been proposed to account for these structures. The early one, "superhelices of coiled DNA filaments," was basically disproved by better ultrastructural preservation and more detailed procedures for cryosubstitution and cryosectioning of vitrified specimens (Gautier et al. 1986 ). Bouligand proposed that the dinoflagellate chromosomes are highly compacted plywoodlike structures, which was confirmed later on by Gautier et al. (1986) . The geometry of the chromosomes, constructed from TEM cross-sections, corresponds to the twisted nematic or cholesteric forms of liquid crystals. The strong birefringence of the dinoflagellate chromosomes is also in agreement with a highly compact and ordered structure of liquid crystals. Freeze-fracture-etch replicas of concentrated DNA solutions were almost identical to TEM images of dinoflagellate chromosomes (Rill et al. 1989) , providing strong support for the cholesteric DNA packing model proposed by Bouligand and Livolant. In most eukaryotic cells, DNA synthesis usually occurs at the end of the chromosomal condensation-decondensation cycle, which is partly mediated by topoisomerases. Ultrastructural and confocal microscopy studies have re-vealed the uniqueness of the dinoflagellate chromosomal behavior during the cell cycle (Rizzo 1981) . Chromosomes appear to be loosely condensed in the early G 1 phase. The boundaries between chromosomes and the nucleoplasm are ruffled because numerous structures protrude toward the nucleoplasm from the chromosomes. In late G 1 phase, the chromosomes remain loosely condensed, but the material inside them appears more densely packed into arch domains. The ruffled aspect of chromosome and nucleoplasm boundaries is absent, and there are very few protruding structures (Bhaud et al. 2000) . During the S phase, the chromosomes are transiently unwound (Spector et al. 1981) . The chromosomes in the G 2 phase are tightly condensed and show a double number of arches when seen under electron microscopy. This quasi-permanently condensed liquid crystal state of the dinoflagellate chromosomes sets unique topological requirements for the topoisomerases.
The major known function of topoisomerase II is in the decatenation of replicated DNA after the S phase. The expression of topoisomerase II is cell cycle dependent, with both protein and catalytic activities peaking at G 2 /M. Studies on the top2 mutant of Saccharomyces cerevisiae revealed that topoisomerase II activity is required specifically at the time of mitosis (Holm et al. 1985) . They showed that the temperature-sensitive top2 mutants were defective in chromosome segregation when they were grown in restrictive temperature. In the parasitic protozoa Leishmania infantum, an analysis of protein expression showed that topoisomerase II is cell cycle-regulated, present in the proliferative stage but absent in the nonreplicating promastigotes (Hanke et al. 2003) . In addition, both the antibodies and the topoisomerase II drug prevented or hindered the segregation of chromatin daughter sets at the anaphase stage of mitosis in drosophila embryos (Buchenau et al. 1993) . Furthermore, immunodepletion of topoisomerase II from Xenopus egg extracts or incubation of these extracts with topoisomerase II inhibitors suggests that topoisomerase II is required for chromatin condensation (Larsen et al. 1996) and chromosome segregation at the metaphase/anaphase transition (Bakshi et al. 2001) . In mammalian cells, upon treatment with topoisomerase II inhibitors, the cell cycle was arrested in the G 2 /M phase. In yeast and Drosophila, there is only one form of topoisomerase II. In contrast, there are two forms of topoisomerase II, the α and β isoforms, in mammalian cells (Bakshi et al. 2001; Champoux 2001; Porter and Farr 2004; Wang 2002) . Topoisomerase IIα,? but not topoisomerase IIβ, is essential for cell proliferation (Bakshi et al. 2001) . Topoisomerase IIα plays a major role in mitosis in mammalian cells, as in other eukaryotes, and its activity is cell cycle-regulated, peaking at the G 2 /M phase. The amount of topoisomerase IIβ, accounting for 20-30% of total topoisomerase II, does not change significantly throughout the cell cycle (Larsen et al. 1996; Prosperi et al. 1992; Taagepera et al. 1993; Woessner et al. 1991) . Topoisomerase IIβ does not seem to be involved in activities specific for a given phase of the cell cycle, as is the case for topoisomerase II in other eukaryotic cells or for the α isoform. More recently, it has been shown that the β isoform is only associated with bulk DNA not undergoing replication (Larsen et al. 1996) . Topoisomerase II levels are also correlated with mitotic activity in plant tissues. In Arabidopsis thaliana, both protein and RNA levels increased with the proliferative state of the cells (Xie and Lam 1994) . A higher level of topoisomerase II expression was also observed in actively dividing and proliferative tissues in pea (Reddy et al. 1999) . The topoisomerase II inhibitor ICRF-193 abrogated chromosome condensation in cultured alfalfa and tobacco cells (Gimenez-Abian et al. 2002) . Available evidences suggest that the major role of topoisomerase II (except the β isoform) in eukaryotes is to ensure proper decatenation of the sister chromatids at the G 2 /M phase.
Cell cycle-phased topoisomerase II activities can be regulated by expression, mRNA, and posttranslational levels (Isaacs et al. 1998) . The transcriptional activation of topoisomerase II is apparently similar to that of most other Sphase-specific genes like DNA polymerase α (Hochhauser et al. 1992; Hu et al. 2002) . The reduced level of topoisomerase II protein after G 2 /M is attributed to the downregulation of transcription and to the decreased stability of both its mRNA and protein (Goswami et al. 1996; Heck et al. 1988 Heck et al. , 1989 Ramachandran et al. 1995) . When dephosphorylated, topoisomerase II from budding yeast and from Swiss 3T3 cells ceases its catalytic activity (Dang et al. 1994; Saijo et al. 1992) . The phosphorylation of topoisomerase II in the fission yeast enhances its nuclear import (Shiozaki and Yanagida 1992).
There are many known inhibitors of topoisomerases. Amsacrine and ellipticine are two specific inhibitors targeting topoisomerase II that stabilize the enzyme-DNA covalent intermediate (Wasserman and Wang 1994) . In addition to topoisomerase II inhibition, amsacrine and ellipticine are known to cause breakage of topoisomerase II-dependent DNA strands in other eukaryotic cells (Larsen et al., 2003) . Because DNA damage is known to affect cell cycle progression, the delay of cell cycle observed in response to topoisomerase II inhibitors could be a consequence of DNA damage (Clarke et al. 1993) . Another class of type II inhibitors, the bis-dioxopiperazine ICRF-193, traps the enzyme in a closed clamp form (Roca et al. 1994 ), which does not stabilize the cleavable complexes between topoisomerase II and the cut DNA. A recent study (Skoufias et al. 2004) showed that ICRF-193 caused DNA decatenation inhibition but not DNA damage. In that experiment, cell cycle arrest relating to ICRF-193 was not accompanied by recruitment of Mad2 or Bub1 to kinetochores, nor by phosphorylation of the histone H2AX; therefore, cell cycle arrest by was not due to the activation of the spindle assembly checkpoint, nor was it a response to DNA damage. Both types of topoisomerase inhibitors will be used in our study.
Topoisomerase activities in dinoflagellates have never been described, but the dinoflagellate cell extract provoked an immunologically positive reaction from an antihuman topoisomerase II polyclonal antibody (Minguez et al. 1994 ).
Due to the unique chromosomal and mitotic features of dinoflagellates, it is questionable whether their topoisomerases play the same role as their counterparts do in other eukaryotes. This study investigated topoisomerase activity during the dinoflagellate cell cycle and tested the effects of topoisomerase II inhibitors on cell cycle progression and chromosome morphology in synchronized Crypthecodiniumcohnii cells.
Materials and methods
Chemical sources, cell culture, and cell cycle synchronization Most of the chemicals, including the topoisomerase II inhibitors amsacrine and ellipticine, and the Spurr resin kit were obtained from Sigma. ICRF-193 was obtained from BIOMOL Research Laboratories Inc. The decatenation assay kit was purchased from TopoGEN Inc, and anti-lamin A+C monoclonal antibodies were purchased from Abcam Limited.
C. cohnii strain 1649 was obtained from the Culture Collection of Algae at the University of Texas in Austin and was cultured in MLH medium (Tuttle and Loeblich 1975) . Cell cycle synchronization was carried out by the colony release-filtration method (Wong and Whiteley 1996) . When C. cohnii colonies on MLH agar plates were washed with fresh medium, only motile G 1 cells were released. The medium containing the newly released cells was subjected to a filtration step (10-μm filter) to increase the proportion of G 1 cells to more than 90%. Synchronized G 1 cells will progress through the cell cycle synchronously, and a new cell cycle will normally start at 10-12 h after synchronization (T=12).
Topoisomerase II inhibitors
To investigate the effects of topoisomerase II deactivation on C.cohnii cell cycle progression, three inhibitors were added at T=0 and T=7, corresponding to the early G 1 and early G 2 /M phases, respectively. Three topoisomerase inhibitors are used, including those that cause DNA damage (amsacrine and ellipticine) and one that does not cause DNA damage (ICRF-193, see "Introduction" section).
Flow cytometric studies Samples (50 ml at approximately 10 4 cells/ml) were harvested at 2-h intervals as the cell cycle progressed. Cells were collected by centrifugation and fixed in 70% ethanol for at least 24 h at 4°C. After fixation, the cells were resuspended in phosphate buffered saline (PBS: 80 mM NA 2 HPO 4 , 20 mM NaH 2 PO 4 , and 100 mM NaCl, pH 7.5) together with RNaseH (5 μg/ml) and incubated at 37°C for 1 h. The cells were then stained with propidium iodide (2.5 μg/ml) at 4°C overnight. Flow cytometry analysis was performed using a Beckon-Dickson Vantage cell sorter.
Fluorescence microscopy
To visualize chromosome morphology, C. cohnii cells were fixed with 2% paraformaldehyde (PFA) prior to DNA staining. After fixation, the samples were stored at 4°C until needed. Before staining, the cells were first washed in PBS and then exposed to SYTOX Green (final concentration at 50 μM in PBS) for 10 min at room temperature. Stained cells were directly mounted for microscopic examination.
Transmission electron microscopy
The control and ICRF-193-treated cells of C.cohnii were fixed, embedded in resin, and examined at ultrastructural level. The standard glutaraldehyde-osmium tetroxide cell fixation protocol was used for specimen preparation. C. cohnii cells were collected by centrifugation at 3,000×g for 10 min. They were fixed for DNA preservation in a primary fixative [4% gluraraldehyde/0.1 M 1,4_piperazinedietha-nesulfonic acid (PIPES) buffer] for at least 1 h at 4°C. After washing the prefixed cells twice in 0.1 M PIPES buffer for 15 min each, to remove any free unreacted glutaraldehyde, the cells were subjected to a secondary fixative (1% osmium tetroxide/0.1 M PIPES buffer) for 1 h at 4°C in the dark. The postfixed cells were subjected to a series of washing, followed by dehydration in ethanol. Finally, the cells were embedded in epoxy resin (from Sigma). Sections were stained with 1% uranyl acetate (dissolved in 50% methanol) and then 0.25% lead citrate (dissolved in 0.1 N NaOH) and were examined in a JEOL 100CX transmission electron microscope.
Analysis of DNA fragmentation by gel electrophoresis C. cohnii cells were collected at 2-h intervals. DNA extraction was performed using a cetyltrimethylammonium bromide (CTAB)-based method (Sambrook and Russell 2001) . Electrophoresis of the extracted genomic DNA was performed in 1% agarose gel for 1 h at 100 V. The DNA smear pattern was observed under a UV lamp after staining with ethidium bromide. Cellular extract preparation for topoisomerase activities C. cohnii cells were harvested at 3-h intervals as the cell cycle progressed, and the dry cell pellets were stored in liquid nitrogen for no more than a week. On the day of assaying, the cells were resuspended in an extraction buffer [1× topoisomerase II assay buffer without adenosine triphosphate (ATP), bovine serum albumin (BSA), or dithiothreitol (DTT), and 1 mM phenylmethylsulfonylfluoride (PMSF), 1 μg/ml aprotinin and pepstatin A, and 10 μg/ml leupeptin]. The cells were treated by ultrasonication at high power until all the cells and nuclei were lysed under microscopic examination. Supernatants, which were obtained after a 15-min centrifugation at 16,000×g at 4°C, were concentrated by centrifugation through a Centricon YM-100 according to the procedures recommended by the manufacturer (Millipore Corporation). We determined the total protein concentration for each extract by using the Bio-Rad protein assay according to the manufacturer's protocol (BioRad Laboratories). Concentrated cellular extract can be immediately subjected to the decatenation assay or stored in liquid nitrogen for no more than a week.
Decatenation assays
Kinetoplastid DNA (kDNA) is a network of concatenated DNA circles. The network consists of several thousands of minicircular DNA. Because topoisomerase II can make a double-strand cut on DNA molecules and then reseal the break, the enzyme thereby has the ability to decatenate the networks of kDNA into individual minicircles. The decatenated minicircles exist in two forms: a nicked open circular (OC) form of 2.5 kb and a relaxed closed circular (CC) form of 1.5 kb. Thus, the activities of topoisomerase II can be measured by investigating the presence of decatenated form(s) of kDNA using a commercially available decatenation assay kit (Topogen Corporation).
The assay was performed according to the protocol provided by the manufacturer. In brief, the kDNA (180 ng) was incubated with 2 μl of cell extracts in 20 μl of 1× reaction buffer [0.05 M Tris-Cl, pH 8.0, 0.12 M KCl, 0.01 M MgCl 2 , 0.5 mM DTT, 0.5 mM ATP, 1 mM ethylenediaminetetraacetic acid (EDTA), and 0.03 μg/μl BSA] at 28°C for 20 min. Preincubation of the kDNA in the 1× reaction buffer at 28°C for 10 min was required. The reaction was stopped by 4 μl of 5× stop buffer with loading dye. The assay products were loaded into a 1.5% agarose gel containing 0.5 μg/ml of ethidium bromide. Electrophoresis was carried out for 2 h at 70 V, and the gel was destained in water for at least 30 min before observation under UV lamp. Nuclei extracts were applied in the decatenation assay, but their results were no different from that when using cellular extracts. Western blot was performed according to the method of Harlow and Lane (1988) . Nuclear lamins A and C were used as loading controls considering that we were purifying a nuclear enzyme and the dinoflagellate permanent nuclear envelopes were previously proven to contain nuclear lamin (Minguez et al. 1994 ).
Single cell gel electrophoresis
The cell preparation and gel electrophoresis were performed with minor modifications of the comet assay methods established for mammalian cells (Hajji et al. 2003; Petersen et al. 2000; Singh et al. 1988) . Cells were embedded in low melting agarose (LMA) in PBS without Ca 2+ and Mg 2+ by using a three-layer technique. Firstly, microscope slides were precovered with 150 μl of 1% LMA. The gel was carefully and evenly spread on the slide with a coverslip (18×18 mm) and left to solidify. The coverslip was then carefully removed. Cells that had been treated with dimethyl sulfoxide (DMSO), amsacrine, and ICRF-193 were harvested 3 h after treatment, and the cell pellets were resuspended in 0.7% LMA, which had been prewarmed to 37°C. Then, 80 μl of the cell suspension was spread evenly with a coverslip on top of the precovered gel and left to solidify for 15 min at 4°C. Finally, after the coverslip was removed, 100 μl of the prewarmed 0.7% LMA was layered on top and left to solidify for 15 min.
Immediately after this preparation, the slides were first immersed in PBS containing 3 U cellulase immediately for 1 h to induce cellulose degradation to weaken the thick cell wall of the C. cohnii. The slides were then immersed in lysis solution (2.5 M NaCl, 100 mM EDTA, 1% N-laurylsarcocine, 10 mM Tris-base, pH 10, with 10% DMSO, and 1% Triton X-100 added just before use) containing 1.5 mg/ml proteinase K for at least 1 h. The DNA was then allowed to unwind for at least 20 min in an electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH 13.2) at 4°C before electrophoresis was run at 20 V for 20 min at 4°C using an ordinary electrophoresis tank. After electrophoresis, the gels were washed in neutralizing buffer (400 mM Tris-HCl, pH 7.5) for 5 min, and the DNA was stained with 10 μM SYTOX Green in PBS for at least 15 min.
Results
Amsacrine and ellipticine caused G1 delay and G2/M arrest Our experiments employed various concentrations of amsacrine and ellipticine to investigate the effect of topoisomerase II deactivation on cell cycle progression. Synchronous C. cohnii cells in the early G 1 phase (at T=0) were exposed to different doses of amsacrine or ellipticine. DNA flow cytograms of the control cells, which were treated only with the vehicle DMSO, confirmed that synchronous cell cycle was accomplished and was back to the G 1 phase again 12 h after synchronization. As shown in the flow cytograms (Fig. 1a) , 5 μM amsacrine and 1 μM ellipticine effectively delayed the synchronous cells at the G 1 and S phase entry if they were added at the beginning of the G 1 phase. The percentage of G 1 cells in amsacrine-and ellipticine-treated cultures displayed approximately 2 h of delay when compared with that in the control culture (Fig. 1c) .
To investigate the effects of the inhibitors on mitosis, the same doses of amsacrine and ellipticine were added 7 h after synchronization (at T=7), when most of the cells already accomplished the S phase, and at the beginning G 2 / M phase. Flow cytograms (Fig. 1b) showed that both drugs also have the ability to arrest C. cohnii cell cycle progression at the G 2 /M phases. The cell cycle progression of the control cells (reentered G 1 at T=12), which were treated with the vehicle DMSO, was not affected.
High concentrations of amsacrine and ellipticine induced DNA fragmentation When higher doses of amsacrine and ellipticine (50 and 10 μM, respectively) were applied, a sub-G 1 area (Fig. 2a) , which indicates possible DNA damage, was observed. Fig. 2b shows DNA-stained photos of the control and amsacrinetreated cells. The rod-shaped chromosomes observed in the control cells could not be seen in amsacrine-treated cells, showing a smeared nucleus instead of individual chromosomes inside the nucleus. This observation is probably caused by DNA damage in the chromosomes. Agarose gel electrophoresis of the genomic DNA of both control and drug-treated cells was performed to determine whether genomic DNA fragmentation occurred (Fig. 2c) . For the control cells, most of the genomic DNA was in the upper region in the gel due to its large molecular size. In contrast, smears of genomic DNA with lower molecular size were observed in amsacrine-treated cells. This result indicated that DNA fragmentation might have occurred in the amsacrine-treated cells, which is consistent with the evidence of the DNA flow cytograms in Fig. 2a .
ICRF-193 delayed S phase entry and arrested cells at G2/M
In this study, the other topoisomerase II inhibitor, ICRF-193, which has a different inhibitory mechanism, was applied to examine its influence on cell cycle progression in synchronous C. cohnii cells. Both flow cytograms and percentage of G1 cells measurement displayed a dose-dependent G 1 delay in cells incubated with (Fig. 3) . When the same doses of ICRF-193 were applied to the cells at the onset of G 2 /M, the cell cycle was severely blocked at this phase, whereas the control cells did not affect cell cycle progression.
Chromosome morphology of C. cohnii cells upon topoisomerase II deactivation
Fluorescence microscopy was applied to our chromosome morphology study, following Bhaud et al. (2000) . Cells were harvested for DNA fluorescence staining at specific time points after synchronization. We employed SYTOX Green, a DNA stain that gives a better resolution of chromosome morphology. The corresponding DNA-stained fluorescence photomicrographs of the control cells at different time points are shown in Fig. 4a . Condensed chromosomes can be observed throughout the C. cohnii cell cycle. The nuclei appeared spherical in early G 1 cells. During the interphase (from T=2 to 6), the chromosomes appeared to be small rods inside the round nuclei with a defined nucleolus. Nuclei enlargement appeared between 2 and 4 h after cell synchronization. Mitotic cells started to appear at 6 h, and they can be categorized into four main groups as defined by Bhaud et al. (2000) . Most of the cells Fig. 1 Effects of amsacrine and ellipticine on synchronous C. cohnii cell cycle progression. Flow cytograms of propidium iodidestained synchronous C. cohnii cells treated with amsacrine and ellipticine. T time in hour that the samples were harvested after cell cycle synchronization. Vehicle dimethyl sulfoxide (DMSO; control), amsacrine (5 μM), and ellipticine (1 μM) were added at T=0 (a) and T=7 (b). Samples were collected at 2-h intervals as the cell cycle progressed. Note that the cell cycle was completed and was back to the G 1 phase 12 h after synchronization in control cells. For amsacrine-and ellipticine-treated cells, G 1 delay was observed when the drugs were added at T=0. G 2 /M delay was observed when the drugs were added at T=7. (c) Percentage of G 1 cells in control and amsacrine-and ellipticine-treated cells for drugs added at T=0 accomplished mitosis at T=10, but the new daughter cells still remained inside the mother cell wall. They were released and formed early G 1 cells thereafter; thus, most of the cells at T=12 are early G 1 cells.
Since ICRF-193 acts as a catalytic inhibitor of topoisomerase II without causing DNA damage, it was applied to deactivate the topoisomerase II in C. cohnii cells (Fig. 4b ). Cells treated with 5 μM of ICRF-193 appeared not to divide at any point in the entire cell cycle. Although clear rod-shaped chromosomes were still observed at T=2, they became unclear (indistinct outline) by T=4. Thereafter, the chromosomes became progressively more obscure, showing a cotton-like structure.
Ultrastructural changes in the C. cohnii chromosomes upon In the control cells (Fig. 5a-c) , which were treated with the vehicle DMSO, the chromosomes exhibited either ellipsoid or round shape, with well-defined entities. Inside the chromosomes, arches and bands were clearly displayed (Fig. 5c ). These patterns are consistent with the ultrastructure of dinoflagellate chromosomes previously described, corresponding to a twisted cholesteric state of liquid crystal. The periphery of the ellipsoid chromosome exhibited a crenulation pattern, which is also a characteristic of dinoflagellate chromosomes.
Compared with the control cells, the ultrastructure of the chromosomes after ICRF-193 treatment became irregular ( Fig. 5d-f) . The well-defined entities were not clear as that of the control C. cohnii cells. The crenulation pattern of the chromosome periphery disappeared, and the characteristic arches and band patterns disappeared. The alignment of the DNA filaments was aberrant and formed an uneven pattern. The DNA filaments inside the chromosome were not as compressed as that of the control and seemed to be stretched and diffused. In summary, the ultrastructure of C. cohnii's chromosomes became totally unorganized upon ICRF-193-induced topoisomerase II deactivation.
Topoisomerase II activities during the C. cohnii cell cycle
In the presence of topoisomerase II activities, catenated kDNA is decatenated into two forms: a nicked OC form and a relaxed CC form. Because only topoisomerase II can perform both double-strand breakage and religation processes, the presence of either or both forms indicates the presence of topoisomerase II activity. As shown in Fig. 6 , OC-form kDNA and linear DNA were produced when the kDNA was incubated with the semipurified cell extracts from C. cohnii. This suggests that topoisomerase II activity is present in C. cohnii cell extract. To confirm that the OC form of kDNA observed in the decatenation assay was produced by topoisomerase II, we challenged the in vitro assay with topoisomerase II inhibitors. At a concentration of 2 mM, either ICRF-193 or amsacrine produced an inhibitory effect on topoisomerase II activity, as indicated by the absence of OC-form kDNA and a nearly 50% decrease in the intensity of the linear bands. The vehicle (DMSO) did not inhibit the decatenating ability of the cell extract, similar to the result of the cell extract study, as only semipurified enzymes were used. Purified human topoisomerase II was reported to have an activity of 0.3 ng kDNA min Durrieu et al. 2000) . We can only approximately estimate the percentage of decatenated kDNA per unit of protein extracts. On this basis, C. cohnii extract has an activity of 281 ng kDNA min −1 mg −1 protein, compared with 0.008 ng kDNA min −1 mg −1 protein in another alveolate Plasmodium berghei (Riou et al. 1986 ).
To investigate topoisomerase II activities in the dinoflagellate C. cohnii cell cycle, we prepared semipurfied cellular extracts obtained at different time points. The variations in topoisomerase II activities during the cell cycle Fig. 7a . The cell extracts used in the assay were equalized to have the same amount of protein, and anti-lamin A and C monoclonal antibodies were used to monitor the loading quantity (Fig. 7b) . In the immunoblot, two bands can be seen at approximately 62 and 75 kDa. The two nuclear lamins remained unchanged throughout the C. cohnii cell cycle. Because dinoflagellates have a permanent nuclear envelope throughout the whole cell cycle, the lamin proteins (which are the major component of the nuclear envelope) should be present throughout the whole cell cycle. After normalizing the DNA bands' intensity, a curve representing the cell cycle variation in topoisomerase II activity was plotted (Fig. 7c) . Topoisomerase II activities were present throughout the whole cell cycle in C. cohnii, but total activity was lowest at T=0. The decrease in activity at this time point might not be a response to the synchronization procedure, as G 1 cells were selected and separated by its phase-dependent mobility and by physical size. No chemicals had been added into the synchronous culture.
DNA damage determination in drug-treated cells Some researchers have reported that ICRF-193 can cause DNA strand breakage in mammalian cells (Hajji et al. 2003) , while others found no DNA damage (Skoufias et al. 2004) or noted that the little damage that they observed was only due to the high pH variation in their study (Boos and Stopper 2000) . When DNA in a mammalian cell has been damaged, it typically shows a comet shape after a single cell gel electrophoresis in strong alkaline solution. This method is sensitive and easy for mammalian cells because their membrane can be easily lysed.
We conducted electrophoresis of single cells to determine whether ICRF-193 would induce DNA damage in C. cohnii. In dinoflagellate cells, a weakened cell wall was still present after cellulose treatment; thus, the DNA could not migrate out of the cell and thus remained inside after electrophoresis. The untreated control cells (Fig. 8a) showed round condensed DNA with the same size as their nuclei. The cells treated with amsacrine (Fig. 8c) experienced DNA fragmentation, with DNA dispersed throughout the whole cell; thus, no round shape could be observed. The cells treated with (Fig. 8b) showed a round DNA shape after single cell electrophoresis, identical to what was observed in the control cells. We observed similar patterns in other concentrations (1 and 5 μM) and confirmed these Topoisomerase II activities can be detected throughout the whole cell cycle in C. cohnii, but its activity was the lowest during the early G 1 phase (T=0) results in three experimental runs. ICRF-193, unlike the topoisomerase poison amsacrine, did not cause observable DNA damage in C. cohnii cells.
Discussion
Topoisomerase II activities are normally required at the G 2 / M phase of the eukaryotic cell cycle. Conversely, topoisomerase II activities are required and are detected during both the G 1 and the G 2 /M phases of the dinoflagellate cell cycle. The only other known exception to the eukaryotic G 2 /M pattern is topoisomerase IIβ, which has no observable cell cycle variation in mammalian cells. However, topoisomerase IIβ is dispensable and its level only accounts for 20-30% of the mammalian enzyme (Akimitsu et al. 2003; Chaly et al. 1996; Woessner et al. 1991) . One possible function of topoisomerase II in the dinoflagellate G 2 /M phase is to promote chromosome segregation during mitosis, as it does in other eukaryotes. However, what is the role of topoisomerase II during the G 1 phase, or before the S phase entry?
Because dinoflagellate chromosomes appear condensed throughout the cell cycle, a question naturally arises: How can genes encoded in such a structure be transcribed and replicated? In higher eukaryotes, these events depend mostly on the dynamic structure of chromatin and nucleosomes (Wolfe 1993) . In dinoflagellates, extrachromosomal DNA loops (formed by local untwisting of DNA filaments at the chromosome peripheries) are a possible site where transcription and replication can occur. In C. cohnii cells, numerous structures protruding from the chromosome core toward the nucleoplasm have been observed during the G 1 phase (Bhaud et al. 2000) .
Our fluorescence photomicrographs show that structural abnormalities started to appear between 2 and 4 h after the beginning of the cell cycle in C. cohnii cells that had been treated with the type II inhibitor (Fig. 4) . The rod-shaped chromosomes became blurred (indistinct outline). TEM photos also showed an irregular chromosomal ultrastructure in ICRF-193-treated cells. This abnormality caused by topoisomerase II inhibition during the G 1 phase suggests that the type II enzyme probably participates in DNA loop formation or organization in dinoflagellate chromosomes. The effect is consistent with topoisomerase II having a role in the transcription and replication of the condensed chromosomes that are characteristic of dinoflagellates. However, we cannot completely exclude the possibility that the cell cycle delay may alternatively be caused by indirect transcription inhibition by the presence of trapped topoisomerase II molecules on the DNA as opposed to a direct requirement for the enzyme in G 1 /S progression.
In most eukaryotic cells, topoisomerase II is essential during the final stages of DNA replication, to facilitate chromosome untangling, condensation, and mitotic segregation. Consequently, the expression levels of topoisomerase II increase several-fold during the late S and G 2 /M phases. However, in our study, topoisomerase II activity was nearly the same as it was during the G 1 phase. Besides the special requirement of topoisomerase II during the G 1 phase, the unique type of mitosis in dinoflagellates might explain the lack of up-regulation during the G 2 /M phase. Bouligand et al. (1968) proposed a DNA liquid crystal structure in the nuclei of dinoflagellates (Spector 1984) . The same authors also suggested that chromosome separation and segregation in dinoflagellates probably depend on liquid crystalline states (Bouligand and Norris 2001) . They proposed that the two replicated filaments are immiscible with the rest of the DNA. This immiscibility occurs in the context of an ordered liquid, with the DNA closely layered in a regular twist, a situation proposed to strongly minimize entangling after replication and, therefore, to strongly facilitate segregation. The liquid crystal DNA structure during mitosis may overcome the relatively low level of topoisomerase II activity during dinomitosis. 
